BREAKING
Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 10 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 11 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 11 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 11 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 12 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 12 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 12 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 12 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 14 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 15 hours ago Zenas BioPharma, Inc. (ZBIO) Reports a Net Loss for Q4 FY25 10 hours ago Dollar Tree, Inc. (DLTR) Beats Q4 Earnings Estimates 11 hours ago CytomX Therapeutics, Inc. (CTMX) Reports Net Loss for FY25 11 hours ago VNET Group, Inc. (VNET) Q4 2025 Revenue Rises 19.6% 11 hours ago VinFast Auto Ltd. (VFS) Reports a Wider Loss for Q4 FY25 12 hours ago Townsquare Media, Inc. (TSQ) Beats Q4 EPS Estimates 12 hours ago Science Applications International (SAIC) Beats Q4 EPS Estimates 12 hours ago Bitcoin Depot Inc. (BTM) Reports Q4 Earnings 12 hours ago NXP Semiconductors (NXPI) Maintains $1.01 Quarterly Dividend, 2.13% Yield With March 25 Ex-Date 14 hours ago Methanex (MEOH) Stock Plunges 10.9% as Q4 Loss of $0.14/Share Misses Estimate by 121.7% 15 hours ago
ADVERTISEMENT
Market News

CorVel shares edge higher after third-quarter revenue and earnings increase

CorVel Corporation (NASDAQ: CRVL) closed at $246.30, up 0.82% on the session, after reporting results for the quarter ended December 31, 2025. The company’s market capitalization stood at $12.6 billion at the close. Latest Quarterly Results (Q3FY26) For the third quarter of fiscal year 2026, CorVel reported revenue of $235.6 million, compared with $228.0 million […]

February 3, 2026 2 min read

CorVel Corporation (NASDAQ: CRVL) closed at $246.30, up 0.82% on the session, after reporting results for the quarter ended December 31, 2025. The company’s market capitalization stood at $12.6 billion at the close. Latest Quarterly Results (Q3FY26) For the third quarter of fiscal year 2026, CorVel reported revenue of $235.6 million, compared with $228.0 million […]

Latest Quarterly Results (Q3FY26)

Segment Highlights

CorVel reports revenue on a consolidated basis across its service platforms. Operational activity during the quarter continued across the Property & Casualty and CERIS businesses.

Financial Trends

For the nine months ended December 31, 2025, CorVel reported revenue of $710.0 million, up from $664.1 million in the corresponding period a year earlier. Net income for the nine-month period was $79.3 million, compared with $68.7 million in the prior-year period. Diluted earnings per share for the nine months were $1.53, up from $1.32 a year earlier.

Business & Operations Update

During the quarter, CorVel advanced technology-driven initiatives across claims management and medical cost containment platforms. The company highlighted continued deployment of automation and analytics across operations.

M&A or Strategic Moves

CorVel reported ongoing integration of a recent strategic acquisition. No new acquisitions or divestitures were announced during the quarter.

Equity Analyst Commentary

Institutional research commentary referenced in public summaries noted steady revenue growth and stable margins, alongside strong liquidity and no borrowings.

Guidance & Outlook — what to watch for

What to watch for includes updates on revenue trends, capital allocation activity, and progress on technology initiatives.

Performance Summary

CorVel shares rose 0.82% at the close. Quarterly revenue reached $235.6 million, with net income of $24.2 million. Earnings per share increased year over year.

ADVERTISEMENT